ANT-1401
BiologicalActive
NCT Number: NCT01951742
The purpose of this study is to establish the therapeutic range of ANT-1401 in the treatment of Crow's Feet.
Looking for future studies?
Notify Me30 year–60 year
All sexes
Interventional
Phase 2
Miami, Florida, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Active
Vehicle
Time frame: Week 4
Crow's Feet Wrinkle Scale
Time frame: up to 12 12 weeks
Subjects self assessment of severity of Crow's Feet
Anterios Inc.
Industry
Dose Finding Study of Botulinum Neurotoxin Type A In Subjects With Crow's Feet (Lateral Canthal Lines)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03839693
Crow's Feet, Lateral Canthal Lines
Miami, Florida, United States
View Trial DetailsNCT03326856
Crow's Feet, Lateral Canthal Lines
Cary, North Carolina, United States
View Trial DetailsNCT03655691
Crow's Feet, Lateral Canthal Lines
Miami, Florida, United States
View Trial DetailsNCT01064518
Crow's Feet, Facial Wrinkles
Coral Gables, Florida, United States
View Trial Details